Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC 1-[4-[[[6-amino-5-(4-phenoxyphenyl)pyrimidin-4-yl]amino]methyl]-4-fluoropiperidin-1-yl]propenone | 1415823-49-2 | 99.9% | C25H26FN5O2 | 10MG
SDP

Supplier:  Medchemexpress LLC HY13948110MG

Encompass_Preferred

TL-895 is a potent, orally active, ATP-competitive, irreversible Bruton's tyrosine kinase (BTK) inhibitor for research use. It exhibits low-nanomolar activity against recombinant BTK, inhibits BTK autophosphorylation, and reduces inflammatory cytokine production and cell migration in preclinical models, supporting its use in studies of B-cell malignancies and myelofibrosis.

  • Potent BTK inhibition at low-nanomolar concentrations.
  • Orally active compound suitable for in vivo studies.
  • Highly selective profile with limited off-target kinase activity.
  • Reduces production of inflammatory cytokines in cell assays.
  • Applicable for preclinical studies of B-cell malignancies and myelofibrosis.

Catalog No. 50-002-60117


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.